Online citations, reference lists, and bibliographies.
← Back to Search

Nasal Route And Drug Delivery Systems

S. Türker, E. Onur, Y. Ozer
Published 2004 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Nasal drug administration has been used as an alternative route for the systemic availability of drugs restricted to intravenous administration. This is due to the large surface area, porous endothelial membrane, high total blood flow, the avoidance of first-pass metabolism, and ready accessibility. The nasal administration of drugs, including numerous compound, peptide and protein drugs, for systemic medication has been widely investigated in recent years. Drugs are cleared rapidly from the nasal cavity after intranasal administration, resulting in rapid systemic drug absorption. Several approaches are here discussed for increasing the residence time of drug formulations in the nasal cavity, resulting in improved nasal drug absorption. The article highlights the importance and advantages of the drug delivery systems applied via the nasal route, which have bioadhesive properties. Bioadhesive, or more appropriately, mucoadhesive systems have been prepared for both oral and peroral administration in the past. The nasal mucosa presents an ideal site for bioadhesive drug delivery systems. In this review we discuss the effects of microspheres and other bioadhesive drug delivery systems on nasal drug absorption. Drug delivery systems, such as microspheres, liposomes and gels have been demonstrated to have good bioadhesive characteristics and that swell easily when in contact with the nasal mucosa. These drug delivery systems have the ability to control the rate of drug clearance from the nasal cavity as well as protect the drug from enzymatic degradation in nasal secretions. The mechanisms and effectiveness of these drug delivery systems are described in order to guide the development of specific and effective therapies for the future development of peptide preparations and other drugs that otherwise should be administered parenterally. As a consequence, bioavailability and residence time of the drugs that are administered via the nasal route can be increased by bioadhesive drug delivery systems. Although the majority of this work involving the use of microspheres, liposomes and gels is limited to the delivery of macromolecules (e.g., insulin and growth hormone), the general principles involved could be applied to other drug candidates. It must be emphasized that many drugs can be absorbed well if the contact time between formulation and the nasal mucosa is optimized.
This paper references
10.1016/0378-5173(88)90087-7
Nasal administration of gentamicin using a novel microsphere delivery system
L. Ilium (1988)
10.1248/BPB.23.323
Usefulness of liposomes as an intranasal dosage formulation for topical drug application.
K. Iwanaga (2000)
10.1023/A:1018927710280
Tolerability and Absorption Enhancement of Intranasally Administered Octreotide by Sodium Taurodihydrofusidate in Healthy Subjects
T. Kissel (2004)
10.1210/JCEM.76.4.8473411
Intranasal administration of human growth hormone (hGH) in combination with a membrane permeation enhancer in patients with GH deficiency: a pharmacokinetic study.
L. Hedin (1993)
The intra-nasal administration of insulin induces significant hypoglycaemia and classical counterregulatory hormonal responses in normal man.
N. Paquot (1988)
10.1016/0378-5173(92)90332-V
Effectiveness of liposomes as adjuvants of orally and nasally administered tetanus toxoid
H. O. Alpar (1992)
Nasal drug delivery systems
YW Chien (1992)
10.1016/S0169-409X(97)00060-4
Intranasal drug delivery.
Hussain (1998)
10.1023/A:1015830907632
The Nasal Mucociliary Clearance: Relevance to Nasal Drug Delivery
N. G. Schipper (2004)
Preparation of desmopressin-con
SL Law (1999)
Intranasal mucociliary of putative bio
Donovan (1985)
10.1016/0378-5173(96)04441-9
Intranasal mucociliary clearance of putative bioadhesive polymer gels
Mengping Zhou (1996)
10.1016/0378-5173(92)90353-4
In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers
C. Lehr (1992)
New antidiabetic drugs
C. J. Bailey (1990)
10.1016/S0168-3659(97)00253-8
Nasal delivery of peptides: an in vitro cell culture model for the investigation of transport and metabolism in human nasal epithelium.
T. Kissel (1998)
10.1111/j.2042-7158.1994.tb03876.x
Nasal Absorption of Desmopressin in Rats and Sheep. Effect of a Bioadhesive Microsphere Delivery System
H. Critchley (1994)
10.1016/S0168-8227(87)80039-6
Effects of intranasal insulin in non-obese type II diabetics.
A. Frauman (1987)
10.1016/0378-5173(88)90236-0
Degradable starch microspheres as a nasal delivery system for insulin
E. Björk (1988)
Effects of intranasal insulin
AG Frauman (1979)
10.1023/A:1018869601502
In Vitro Evaluation of Microparticles and Polymer Gels for Use as Nasal Platforms for Protein Delivery
C. Witschi (2004)
10.1177/106002809402800703
Nasal Absorption of Growth Hormone in Normal Subjects: Studies with Four Different Formulations
T. Laursen (1994)
10.1080/02652040050161765
Preparation and in vitro characterization of gelatin microspheres containing Levodopa for nasal administration.
B. Brime (2000)
10.1016/S0169-409X(97)00064-1
Optimization of systemic nasal drug delivery with pharmaceutical excipients.
Roméo (1998)
ministered insulin in rats
R Deponti (1991)
10.1016/S0169-409X(98)00073-8
Intranasal insulin delivery and therapy.
Hinchcliffe (1999)
10.1111/j.1464-5491.1992.tb01792.x
Intranasal Administration of Insulin With Phospholipid as Absorption Enhancer: Pharmacokinetics in Normal Subjects
K. Drejer (1992)
Nasal absorption of nifed
K Morimoto (1992)
10.1152/JAPPL.1977.43.1.46
Effects of exercise and eucapnic hyperventilation on bronchial clearance in man.
R. Wolff (1977)
10.1016/0378-5173(90)90126-O
Investigation of the nasal absorption of biosynthetic human growth hormone in sheep—use of a bioadhesive microsphere delivery system
L. Illum (1990)
Drug delivery systems for nasal application
L Illum (1985)
10.1016/0378-5173(89)90262-7
Enhanced nasal absorption of insulin in rats using lysophosphatidylcholine
L. Illum (1989)
10.1097/00005537-200002010-00025
Long‐Term Use of Preservatives on Rat Nasal Respiratory Mucosa: Effects of Benzalkonium Chloride and Potassium Sorbate
J. Cho (2000)
The bioavaila
WA (1992)
10.1023/A:1015872617511
Effects of Absorption Enhancers on Human Nasal Tissue Ciliary Movement in Vitro
W. Hermens (2004)
10.1016/0168-3659(90)90016-M
Nasal administration of insulin using bioadhesive microspheres as a delivery system
N. Farraj (1990)
human nasal epithelium
D Ridley (1998)
10.1023/A:1018911206646
Drug Metabolism in the Nasal Mucosa
Mohamadi A. Sarkar (2004)
10.1016/S0169-409X(97)00058-6
Anatomy, physiology and function of the nasal cavities in health and disease.
Dahl (1998)
10.1016/0378-5173(90)90232-S
Characterization of degradable starch microspheres as a nasal delivery system for drugs
E. Björk (1990)
10.1248/CPB.40.1569
Permeability of insulin entrapped in liposome through the nasal mucosa of rabbits.
Y. Maitani (1992)
Insulin analogues and nasal insulin
S Jorgensen (1994)
Nasal and sublingual administration of insulin in man
T Yokosuka (1977)
10.1111/j.2042-7158.1987.tb03398.x
The effect of molecular size on the nasal absorption of water‐soluble compounds in the albino rat
A. Fisher (1987)
10.1016/0378-5173(82)90002-3
Effect of polymers and microspheres on the nasal absorption of insulin in rats
L. Rydén (1992)
adhesive polymer gels
Merkus FWHM (1996)
10.2337/diab.32.11.1040
Insulin Administered Intranasally as an Insulin-Bile Salt Aerosol: Effectiveness and Reproducibility in Normal and Diabetic Subjects
A. Moses (1983)
10.1016/0378-5173(91)90081-X
PREPARATION AND CHARACTERIZATION OF HSA - PROPRANOLOL MICROSPHERES FOR NASAL ADMINISTRATION
S. P. Vyas (1991)
10.1111/j.2042-7158.1985.tb05024.x
Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel
K. Morimoto (1985)
10.1111/j.2042-7158.1994.tb03877.x
The Distribution of an Intranasal Insulin Formulation in Healthy Volunteers: Effect of Different Administration Techniques
S. Newman (1994)
10.1016/S0169-409X(97)00069-0
Microspheres as nasal drug delivery systems.
Pereswetoff-Morath (1998)
10.1081/DDC-100102275
The relationship between the rigidity of the liposomal membrane and the absorption of insulin after nasal administration of liposomes modified with an enhancer containing insulin in rabbits.
K. Muramatsu (1999)
10.1016/S0168-3659(00)00369-2
Preparation of desmopressin-containing liposomes for intranasal delivery.
S. Law (2001)
10.1007/s004050100339
Prostaglandin E2 activates the ciliary beat frequency of cultured human nasal mucosa via the second messenger cyclic adenosine monophosphate
B. Haxel (2001)
The intranasal
N Paquot (1985)
Preparation and in vitro
B Brime (1992)
10.1016/0378-5173(87)90216-X
Bioadhesive microspheres as a potential nasal drug delivery system
L. Illum (1987)
10.2337/diacare.14.2.30
Insulin Administration
(1991)
10.1136/thx.48.3.287
Effect of oral bronchodilators on lung mucociliary clearance during sleep in patients with asthma.
A. Hasani (1993)
10.1023/A:1018992716621
The Bioavailability of Intranasal Salmon Calcitonin in Healthy Volunteers with and Without a Permeation Enhancer
W. Lee (2004)
10.3109/03639049109026627
Use of Chemical Enhancers for Nasal Drug Delivery
R. Ponti (1991)
10.1023/A:1015896405389
Absorption Enhancing Effect of Cyclodextrins on Intranasally Administered Insulin in Rats
F. H. H. M. Merkus (2004)
10.1016/S0169-409X(97)00059-8
Nasal mucociliary clearance as a factor in nasal drug delivery.
Merkus (1998)
10.1164/AJRCCM/151.3_PT_1.630
Ciliary abnormalities in bronchial epithelium of smokers, ex-smokers, and nonsmokers.
F. Verra (1995)
The importance of intranasal route for application of drugs and nasal drug delivery systems
AY Özer (1990)
The effect of posture on nasal clearance of bioadhesive starch microspheres
D. Ridley (1995)
10.1056/NEJM198504253121702
Intranasal aerosolized insulin. Mixed-meal studies and long-term use in type I diabetes.
R. Salzman (1985)
10.1016/S0378-5173(01)00708-6
Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides.
L. Illum (2001)
10.1201/b14196
Novel Drug Delivery Systems
Y. Chien (1991)
10.1248/CPB.35.3041
Nasal absorption of nifedipine from gel preparations in rats.
K. Morimoto (1987)



This paper is referenced by
10.1016/J.IJPARA.2006.07.006
Treatment of malaria in a mouse model by intranasal drug administration.
E. Touitou (2006)
10.3390/pharmaceutics12070678
Antimicrobial Essential Oil Formulation: Chitosan Coated Nanoemulsions for Nose to Brain Delivery
F. Rinaldi (2020)
10.3109/07388551.2010.483460
Mitigating the looming vaccine crisis: production and delivery of plasmid-based vaccines
Clarence M. Ongkudon (2011)
10.1155/2018/9285854
Protein Based Nanostructures for Drug Delivery
D. Verma (2018)
10.1517/17425247.2012.662484
Leuprolide acetate: pharmaceutical use and delivery potentials
D. Teutonico (2012)
10.1371/journal.pone.0053314
Preparation and Efficacy of a Live Newcastle Disease Virus Vaccine Encapsulated in Chitosan Nanoparticles
K. Zhao (2012)
A Holistic Review on Nasoadhesive Microsphere
A. Mishra (2014)
10.4236/JBNB.2012.32025
Modular Hydrogels for Drug Delivery
S. Simões (2012)
ROSUVASTATIN CALCIUM BIOADHESIVE BUCCAL TABLETS FORMULATION AND EVALUATION
S.Duraivel (2013)
A REVIEW ON GELS AS A NASAL DRUG DELIVERY SYSTEM
R PatilDevayani (2013)
10.1038/srep14418
Assessment of C-phycocyanin effect on astrocytes-mediated neuroprotection against oxidative brain injury using 2D and 3D astrocyte tissue model
S. K. Min (2015)
10.1007/978-1-4939-1417-3_15
Nasal Administration of Vaccines
R. Scherließ (2015)
10.1080/10611860802556842
Mucoadhesive microspheres for nasal administration of cyclodextrins
E. Gavini (2009)
10.5530/RJPS.2012.1.4
Nasal drug delivery–a review
Twarita Deshpande (2012)
10.12968/JPAR.2012.4.12.699
Use of intranasal drug administration in the pre-hospital setting
Chloe Creed (2012)
10.1016/j.otc.2010.02.012
Novel topical therapeutics.
B. Bleier (2010)
10.4333/KPS.2009.39.6.417
Budesonide Microemulsions for Enhancing Solubility and Dissolution Rate
Hong-Mei Piao (2009)
10.1021/acs.molpharmaceut.5b00264
Feasibility Investigation of Cellulose Polymers for Mucoadhesive Nasal Drug Delivery Applications.
Kellisa Hansen (2015)
10.1201/B19976-6
Nanoparticulate Systems for Dental Drug Delivery
S. Nguyen (2016)
10.1146/annurev.bioeng.10.061807.160544
Targeted drug-aerosol delivery in the human respiratory system.
C. Kleinstreuer (2008)
10.3109/10717544.2015.1120364
Comparative study between simple and optimized liposomal dispersion of quetiapine fumarate for diffusion through nasal route
Pratik Upadhyay (2016)
10.2217/nnm.14.206
Nanomedicine for the treatment of Alzheimer's disease.
M. Gregori (2015)
10.4103/aer.AER_119_17
Comparison of Intranasal Dexmedetomidine Compared to Midazolam as a Premedication in Pediatrics with Congenital Heart Disease Undergoing Cardiac Catheterization
M. M. Messeha (2018)
10.1016/J.VACCINE.2007.03.038
Pluronic F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxin.
M. L. Kang (2007)
10.1016/j.colsurfb.2020.110974
Development of a microemulsion for encapsulation and delivery of gallic acid. The role of chitosan.
Evgenia Mitsou (2020)
10.1002/9780470944349.CH10
Modified Natural Polysaccharides as Nanoparticulate Drug Delivery Devices
A. Bhaw-Luximon (2010)
10.2174/0929867326666190827151741
Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery.
Areen Alshweiat (2019)
10.1097/01.IAE.0000244275.03588.AD
Crystalline retinopathy from nasal ingestion of methamphetamine.
R. L. Kumar (2006)
CHALLENGES IN ALTERNATIVE INSULIN DELIVERY SYSTEM: A REVIEW
Kapil R. Bare (2011)
10.1201/B19976-6
Nanotechnology for Pulmonary and Nasal Drug Delivery
Helene Dugas (2016)
10.1201/B20045-11
Overview of Polyester Nanosystems for Nasal Administration
Imran Vhora (2016)
10.1016/j.jsps.2016.07.003
Direct and enhanced delivery of nanoliposomes of anti schizophrenic agent to the brain through nasal route
Pratik Upadhyay (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar